Home           About Us           Enquires           Contact Us           Links
Information
 
Publications
Recent developments in pharmacoeconomic evaluation in Ireland

Lesley Tilson, Michael Barry. Expert Review of Pharmacoeconomics & Outcomes Research, June 2010, Vol. 10, No.3, Pages 221-224.


  Website Link
Public drug expenditure in the Republic of Ireland

Michael Barry, Cara Usher, Lesley Tilson.  Expert Review of Pharmacoeconomics & Outcomes Research, June 2010, Vol. 10, No. 3, Pages 239-245.


  Website Link
Reimbursement of new high cost drugs - Funding the unfundable?

Barry M, Tilson L. IMJ May 2010; 103 (5): 133.


  Website Link
Understanding the Relationship between EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis.

Pharmacoeconomics 2010;28(6):477-487. Adams Roisin, Walsh Cathal, Veale Douglas, Bresnihan Barry, Fitzgerald Oliver, Barry Michael.


  Website Link
Pharmacoeconomic Evaluation in Ireland: A Review of the Process

Tilson L, O'Leary A, Usher C, Barry M. Pharmacoeconomics 2010;28(4) [early online].


  Website Link
Estimating Drug Costs in Economic Evaluations in Ireland and the UK: An Analysis of Practice and Research Recommendations.

Hughes DA, Tilson L, Drummond M. Pharmacoeconomics 2009;27(8):635-43.

A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Knee Replacement in the Irish Health Care Setting

McCullagh L, Tilson L, Walsh C, Barry M. Pharmacoeconomics 2009;27(10):829-846

Drug expenditure in Ireland 1997 - 2007.

M Barry, D Molloy, C Usher, L Tilson. IMJ Dec 2008. Vol. 101; No: 299 - 302.


  Website Link
Cost effectiveness of HPV vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 & 18 using a transmission dynamic model.

Usher C, Tilson L, Olsen J, Jepsen M, Walsh C, Barry M. Vaccine 2008 Oct 16;26(44):5654-61.

Cost effectiveness of treatments reducing coronary heart disease mortality in Ireland 2000 to 2010.

Bennett K, Kabir Z, Barry M, Tilson L, Fidan D, Capewell S. Value in Health January/February 2009 Volume 12 Issue 1.

The cost effectiveness of cotrimoxazole prophylaxis in HIV infected children in Zambia.
Ryan M, Griffin S, Chitah B, Walker A, Mulenga V, Kalola D, Hawkins N, Merry C, Barry M, Chintu C, Sculpher M, Gibb D.
AIDS 2008; 22 (6): 749-757.
The utilisation and expenditure of medicines for the prophylaxis and treatment of osteoporosis.
McGowan B, Bennett K, Barry M, Canny M.
IMJ 2008; 101 (2): 38-41.

  Website Link
Economic Evaluation of a Universal Childhood Pneumococcal Conjugate Vaccination Strategy in Ireland.

Tilson L, Usher C, Butler K, Fitzsimons J, O'Hare F, Cotter S, O'Flanagan D, Johnson H, Barry M.  Value in Health. 2008 May 16. [Epub ahead of print] PMID: 18489504

Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation

Lesley Tilson, Lelia Thornton, Darina O’Flanagan, Howard Johnson, Michael Barry.  European Journal of Public Health. Jun 2008;18(3):275-82.

Recent developments in pricing and reimbursement of medicines in Ireland
Michael Barry & Lesley Tilson.
Expert Rev. Pharmacoeconomics Outcomes Res. 7(6), 605 - 611 (2007).
Best practice for Helicobacter Pylori Eradication in the primary care setting
Walshe V, O'Morain C, Bennett K, Keeling PWN, Barry M. IMJ June 2006; vol 99 (1): 11-12
  Website Link
Cost effectiveness of statin therapy for the primary prevention of coronary heart disease
Walshe V, Nash A, Barry M. IMJ. 2006: 99 (5): 144-145
  Website Link
The rising cost of glaucoma drugs in Ireland 1996 - 2003
FA Knox, M Barry, B McGowan, C O'Brien. Br J Ophthalmol 2006,.90: 162-165.
  Website Link
The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland
Lesley Tilson, Kathleen Bennett, Michael Barry.Eur J Health Economics Sep 2005 Vol 6 Issue 3. 267-273
  Website Link
European Pharmaceutical Pricing and Reimbursement Strategies (2005). .

Lesley Tilson & Michael Barry.  To order a copy of this publication please contact the NCPE by phone (01 4103427) or email (info@ncpe.ie).

Cost Effective Prescribing of Proton Pump Inhibitors (PPI's) in the GMS Scheme
B McGowan, K Bennett, L Tilson, M Barry. IMJ March 2005 Vol. 98 No. 3, 78 - 80
Download Document Website Link
Prescribing trends for Nicotine Replacement Therapy in Primary Care
L Tilson, K Bennett, M Barry. IMJ Oct 2004 Vol 97 No. 9, 270-273
  Website Link
The high cost of medicines in Ireland. Is it time to change the pricing mechanism?
Lesley Tilson, Bernadette McGowan, Kathleen Bennett and Michael Barry.Eur J Health Economics.The original article is available at:
  Website Link
Population Based Study of the Cost of Inpatient Care for HIV Infected Individuals in an Irish Teaching Hospital
M Ryan, C Merry, C Ryan, K Bennett, A Heerey, B McGowan, F Mulcahy, M Barry.IMJ July/August 2004 Vol 97 No 7.200-202
  Website Link
Patient Co-payment for Prescription Medicines Across Europe - How do we compare
M Barry, L Tilson, M Ryan IMJ March 2004:97(3):69-70.The original article is available at :
  Website Link
Pricing and reimbursement of drugs in Ireland
Michael Barry, Lesley Tilson, Mairin Ryan. Eur J Health Economics. Vol 5 no.2, 2004.190 - 194.The original publication is available at :
  Website Link
Cost of treating Stroke in an Irish teaching hospital
B McGowan, A Heerey, L Tilson, M Ryan, M Barry. IMJ Sept 2003;96(8):234-236.
Download Document Website Link
Generic Drug Utilisation on the General Medical Services Scheme in 2001
Tilson L, McGowan B, Ryan M, Barry M. IMJ June 2003;96(6):176-179.
Download Document Website Link
Cost-Effectiveness of Spironolactone in Patients with Severe Heart Failure
Tilson L, McGowan B, Ryan M, Barry M. IJMS 2003;172(2):70-72.
Download Document  
Decision-making by healthcare payers
M Levine, R Taylor, M Ryan, M Sculpher. Respiratory Medicine August 2002 Vol. 96 (Suppl C) S3-S10.
  Website Link
Cost-Effectiveness of Beta Blocker Therapy for Patients with Chronic Severe Heart Failure in Ireland
M Barry. IMJ June 2002;95(6):174-177.
Download Document  
Cost-Effectiveness of Statins for the Secondary Prevention of Coronary Heart Disease in Ireland
M Barry, A Heerey. IMJ May 2002;(95):133-135.
  Website Link
Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation
A Heerey, B McGowan, M Ryan, M Barry, Expert Rev. Pharmacoeconomics Outcomes Res. 2(1), 29-33 (2002)
Download Document  
Cost of treating Heart Failure in an Irish teaching hospital
B McGowan, A Heerey, M Ryan, M Barry. IJMS 2001;169(4):241-244.
Download Document  
The potential for drug interactions with statin therapy in Ireland
A Heerey, M Barry, M Ryan, A Kelly. IJMS 2001;169(3):176-179.
Download Document  
Cost of treating acute myocardial infarction in an Irish teaching hospital
A Heerey, B McGowan, M Ryan, J Feely, M Walsh, M Barry. IMJ 2001;94(5):144-146.
Download Document  
Alternative approaches to the economic evaluation of a drug for patients with Alzheimers Disease.
D McCulloch, A Heerey, M Ryan, M Barry. EHP 2000;6(2):64-68.
Download Document  
Drug Reimbursement in Ireland
M Barry, A Heerey, J Feely. IMJ 2000;93(3):71-72.
Click here for more

Download Document  
The Scientific evaluation of Drugs – Pharmacoeconomics Applied
M Barry, J Feely, D McCulloch. IPJ 2000;78(2):66-69
  Website Link
Pharmacoeconomics in Ireland – concepts and terminology
M Barry, J Feely. IJMS 2000;169(1);63-64.
Download Document  
Pharmacoeconomics of lipid lowering therapy in Ireland
M. Barry, A Heerey, O Sheehan, M Ryan, D McCulloch, J Feely. IMJ 1999;92; 7; 430-432
  Website Link
The Irish National Centre for Pharmacoeconomics: Its Rationale and Role
M Barry, A Heerey, D McCulloch, M Ryan, C Merry, C Hughes, J Feely. IMJ 1999;92(4):337-339.
Download Document  
Rialto Gate, St. James's Hospital, Dublin 8, Ireland. Design & Development by Nexus451